-Institute of Genetics, International School of Medicine, Zhejiang University
-The Fourth Affiliated Hospital, Zhejiang University School of MedicineResearch
Research Direction: Epigenetic regulation
In the past years, Dr. Chih-Hung Hsu’s researches include:
1) Demonstration of RNA methylation (m6A) as a stimuli-response factor for environmental stresses (National Science Review 2023, highlighted in AAAS/EurekAlert!；Cell Reports 2022, Cover Article；Nature Communications 2022；Nature 2017, highlighted in Nature Reviews Molecular Cell Biology, Cancer Discovery, Science Signaling, and F1000);
2) Hyperthermia-mediated destabilization of abnormal cellular factors (Cell Reports 2022, Cover Article；Research 2022；Blood Cancer Discovery 2021, commented in Blood Cancer Discovery: Spotlight);
3) Investigation of the roles of Epi-markers in distinct oncological bioprocesses (Cell Reports 2012, selected into Cell Reports Best of 2012, commented in Nature Reviews Cancer, highlighted by Cell and Cell Reports websites；EMBO Journal 2004；Oncogene 2012；Frontiers in Oncology 2022);
4) Identifying new regulatory complexes and a new EZH2 inhibitor (Theranostics 2021；Theranostics 2020；Nucleic Acids Research 2019)
